Related Experiment Video
Updated: Jun 24, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Early statin treatment following acute myocardial infarction and 1-year survival
1Department of Cardiology, University Hospital of Linköping, SE 581 85 Linköping, Sweden. stenestrand@riks-hia.c.se
Insights
Early statin treatment after acute myocardial infarction (AMI) significantly reduces 1-year mortality. This finding supports the widespread use of statins in AMI patients for improved survival outcomes.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials and Outcomes
- Pharmacological Interventions
Background:
- Randomized trials confirm statins for secondary prevention in coronary artery disease.
- The impact of early statin initiation post-acute myocardial infarction (AMI) on survival remains under investigation.
Purpose of the Study:
- To assess the association between statin therapy initiated at or before hospital discharge and 1-year mortality in AMI survivors.
Main Methods:
- Prospective cohort study utilizing data from the Swedish Register of Cardiac Intensive Care (1995-1998).
- Included 5,528 patients receiving early statins and 14,071 not receiving statins, all younger than 80 years and discharged alive after a first AMI.
- One-year mortality data sourced from the Swedish National Cause of Death Register.
Main Results:
- Unadjusted 1-year mortality was 4.0% in the statin group versus 9.3% in the no-statin group.
- Adjusted regression analysis revealed early statin use was associated with a 25% reduction in 1-year mortality (RR, 0.75; 95% CI, 0.63-0.89; P=.001).
- Mortality reduction was consistent across subgroups defined by age, sex, baseline characteristics, and prior medical history.
Conclusions:
- Early statin initiation following AMI is linked to a significant decrease in 1-year mortality.
- Highlights the importance of applying findings from randomized statin trials to unselected AMI patient populations.
Context:
Randomized trials have established statin treatment as secondary prevention in coronary artery disease, but it is unclear whether early treatment with statins following acute myocardial infarction (AMI) influences survival.
Objective:
To evaluate the association between statin treatment initiated before or at the time of hospital discharge and 1-year mortality after AMI.
Design And Setting:
Prospective cohort study using data from the Swedish Register of Cardiac Intensive Care on patients admitted to the coronary care units of 58 Swedish hospitals in 1995-1998. One-year mortality data were obtained from the Swedish National Cause of Death Register.
Patients:
Patients with first registry-recorded AMI who were younger than 80 years and who were discharged alive from the hospital, including 5528 who received statins at or before discharge and 14 071 who did not.
Main Outcome Measure:
Relative risk of 1-year mortality according to statin treatment.
Results:
At 1 year, unadjusted mortality was 9.3% (1307 deaths) in the no-statin group and 4.0% (219 deaths) in the statin treatment group. In regression analysis adjusting for confounding factors and propensity score for statin use, early statin treatment was associated with a reduction in 1-year mortality (relative risk, 0.75; 95% confidence interval, 0.63-0.89; P =.001) in hospital survivors of AMI. This reduction in mortality was similar among all subgroups based on age, sex, baseline characteristics, previous disease manifestations, and medications.
Conclusions:
Early initiation of statin treatment in patients with AMI is associated with reduced 1-year mortality. These results emphasize the importance of implementing the results of randomized statin trials in unselected AMI patients.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

